Affiliation:
1. Department of Pediatrics, School of Medicine, Tufts University and Tufts Medical Center, Boston, Massachusetts
Abstract
Despite the established safety and efficacy of the measles-mumps-rubella vaccine after almost 50 years of widespread use, the United States is encountering higher levels of measles and mumps disease than has occurred for years. Return of disease threatens the health of those who remain unimmunized by choice as well as those who are immunized appropriately but experience loss of vaccine-induced immunity. The solution to continued threats of illness caused by these untreatable but readily preventable diseases is compliance with recommendations for administration of the measles-mumps-rubella vaccine. Here we examine trends in the epidemiology of measles, mumps, and rubella in recent years and consider the consequences of loss of protective immunity within our country.
Publisher
American Academy of Pediatrics (AAP)
Subject
Pediatrics, Perinatology, and Child Health
Reference29 articles.
1. Centers for Disease Control and Prevention. Manual for the Surveillance of Vaccine-Preventable Diseases. Chapter 7: Measles. Available at https://www.cdc.gov/vaccines/pubs/surv-manual/chpt07-measles.html. Accessed June 17, 2020
2. Recommendation of the Advisory Committee on Immunization Practices for use of a third dose of mumps virus-containing vaccine in persons at increased risk for mumps during an outbreak;Marin;MMWR Morb Mortal Wkly Rep,2018
3. Mumps outbreak at a university and recommendation for a third dose of measles-mumps-rubella vaccine - Illinois, 2015–2016;Albertson;MMWR Morb Mortal Wkly Rep,2016
4. Centers for Disease Control and Prevention. Measles cases and outbreaks. Available at: https://www.cdc.gov/measles/cases-outbreaks.html. Accessed January 12, 2020
Cited by
7 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献